← Leaderboards
Vincent M Monnier
Case Western Reserve University
$7,884,560
Attributed
$9,424,766
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2006–21$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$9,424,766 · 9
By mechanism
R01$7,601,877 · 3
DP3$1,063,615 · 1
P01$725,274 · 3
R13$34,000 · 2
Top collaborators
- Rong Xu3 shared
- Patricia Ann Cleary2 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Ram H Nagaraj$14,900,043
- Patricia Ann Cleary$531,808
Others in their field
Top investigators on “Aging”
- Lawrence Corey · Fred Hutchinson Cancer Center$506,603,345
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,438,389
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$281,021,854
- George R Seage · Abt Associates, Inc.$218,167,298
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$210,610,900
Research focus
AgingProteinsArginineOrnithineCataractLaboratory RatAntioxidantsOxidationCrystallinsLensGlycationLysineIn VitroAnimal ModelMouse ModelHuman TissueStressDiabetes MellitusGlutathioneBaseGeneticCrosslinkAscorbateAge Related
Grant awards (33)
Repositioning of Clinically Approved Drugs toward the Prevention and Risk Evaluation of Early Cataract Progression$658,609
R01 · FY2021 · EY · contact PI
Repositioning of Clinically Approved Drugs toward the Prevention and Risk Evaluation of Early Cataract Progression$678,627
R01 · FY2020 · EY · contact PI
Repositioning of Clinically Approved Drugs toward the Prevention and Risk Evaluation of Early Cataract Progression$679,562
R01 · FY2019 · EY · contact PI
Amino-Carbonyl Reactions in the Aging Human Lens$348,477
R01 · FY2016 · EY · contact PI
Amino-Carbonyl Reactions in the Aging Human Lens$394,343
R01 · FY2015 · EY · contact PI
Amino-Carbonyl Reactions in the Aging Human Lens$394,343
R01 · FY2014 · EY · contact PI
Metabolic Markers of Carbonyl, Oxidative and Nitrosative Stress in the DCCT/EDIC$1,023,615
DP3 · FY2013 · DK · contact PI
Amino-Carbonyl Reactions in the Aging Human Lens$382,271
R01 · FY2013 · EY · contact PI
Metabolic Markers of Carbonyl, Oxidative and Nitrosative Stress in the DCCT/EDIC$40,000
DP3 · FY2013 · DK · contact PI
Amino-Carbonyl Reactions in the Aging Human Lens$402,391
R01 · FY2012 · EY · contact PI
Amino-Carbonyl Reactions in the Aging Human Lens$371,299
R01 · FY2010 · EY · contact PI
Amino-Carbonyl Reactions in the Aging Human Lens$375,049
R01 · FY2009 · EY · contact PI
10th International Symposium on the Maillard Reaction$17,500
R13 · FY2009 · AG · contact PI
Amino-Carbonyl Reactions in the Aging Human Lens$367,548
R01 · FY2008 · EY · contact PI
Amino-Carbonyl Reactions in the Aging Human Lens$375,049
R01 · FY2007 · EY · contact PI
9th International Symposium on the Maillard Reaction$16,500
R13 · FY2007 · AG · contact PI
Amino-Carbonyl Reactions in the Aging Human Lens$386,250
R01 · FY2006 · EY · contact PI
COLLAGEN CROSSLINKING BY THE MAILLARD REACTIOIN IN AGING$229,500
R01 · FY2004 · AG
COLLAGEN CROSSLINKING BY THE MAILLARD REACTIOIN IN AGING$229,500
R01 · FY2003 · AG
COLLAGEN CROSSLINKING BY THE MAILLARD REACTIOIN IN AGING$229,500
R01 · FY2002 · AG
Core--Animal facility$94,628
P01 · FY2002 · DK
Oxidant stress &ascorbic acid processing in diabetes$94,628
P01 · FY2002 · DK
COLLAGEN CROSSLINKING BY THE MAILLARD REACTIOIN IN AGING$282,445
R01 · FY2001 · AG
AMINO-CARBONYL REACTIONS IN THE AGING HUMAN LENS$254,814
R01 · FY2001 · EY
Oxidant stress &ascorbic acid processing in diabetes$94,628
P01 · FY2001 · DK
Core--Animal facility$94,628
P01 · FY2001 · DK
COLLAGEN CROSSLINKING BY THE MAILLARD REACTIOIN IN AGING$30,000
R01 · FY2001 · AG
CORE--ANIMAL$0
P01 · FY2001 · AG
COLLAGEN CROSSLINKING BY THE MAILLARD REACTIOIN IN AGING$282,680
R01 · FY2000 · AG
AMINO-CARBONYL REACTIONS IN THE AGING HUMAN LENS$249,620
R01 · FY2000 · EY
CORE--ANIMAL$157,506
P01 · FY2000 · AG
Core--Animal facility$94,628
P01 · FY2000 · DK
Oxidant stress &ascorbic acid processing in diabetes$94,628
P01 · FY2000 · DK